While large-cap stocks offer stability, their massive scale often limits growth. We analyze three market leaders, identifying one with compelling potential and two where the current story may be fully priced in.
As earnings season winds down, the construction and maintenance services sector showed resilience. Great Lakes Dredge & Dock posted solid results despite a revenue miss, while peers like Primoris soared. We analyze the key drivers and what's next for these industrial players.
Goldman Sachs and Evercore ISI analysts have raised price targets for GE HealthCare Technologies (GEHC), citing a projected market recovery and strong capital expenditure trends by 2026. The medical devices firm is highlighted as a top hedge fund pick.
Analyst Matthew O'Brien reaffirms an Overweight rating and $420 price target for Stryker, highlighting the potential of its new Mako RPS handheld orthopedic robot to capture cost-sensitive markets and compete with rivals like Zimmer Biomet.
DexCom Inc. (DXCM) has released preliminary Q4 figures that exceeded expectations and provided robust long-term guidance, reinforcing its position as a favored pick among analysts and hedge funds in the medical devices sector.
Wall Street analysts are raising price targets on Edwards Lifesciences, citing a renewed growth cycle driven by TAVR expansion and a strong product pipeline, positioning the medical device maker as a favored pick.
Brunswick Corporation surpassed Q4 revenue and profit expectations, buoyed by stabilizing retail demand. However, a cautious near-term forecast and persistent tariff headwinds cloud its 2026 trajectory, highlighting the complex currents facing the marine industry.
SLB has won significant five-year contracts from Petroleum Development Oman for the giant Block-6 field. The deals mandate local wellhead manufacturing and deploy advanced recovery technologies, anchoring SLB's long-term service role and supporting Omani job creation.
Uber's strategic investment in self-driving startup Waabi, founded by its former AI chief, signals a major push into robotaxis. The $1 billion deal underscores Uber's sprawling portfolio of over 20 AV partnerships, raising questions about its 'bet-on-everything' approach in the high-stakes race for autonomy.
Bitcoin's sharp decline this week mirrors a wider market rout, with analysts pointing to a confluence of geopolitical tensions, policy fears, and tech sector volatility as key drivers. The sell-off raises fresh questions about near-term support levels for the flagship cryptocurrency.
BlackRock has increased its stake in the diversified precious metals miner Sibanye-Stillwater beyond 5%, signaling strong institutional confidence amid a historic rally in gold and platinum group metals. We examine the drivers behind the surge and what it means for investors.
Insulet (PODD) shares have faced significant pressure in recent months, diverging from the company's underlying business performance. This analysis delves into whether the current price weakness presents a buying opportunity for the Omnipod maker or reflects deeper market concerns about its premium valuation and growth sustainability.
HSBC has raised its rating on New Oriental Education & Technology Group (NYSE: EDU) from 'Hold' to 'Buy', following the company's better-than-expected Q2 FY2026 results. The upgrade highlights a robust recovery in core businesses and strategic expansion into new educational initiatives.
Autonomous driving leader Pony AI partners with premium mobility provider Beijing ATBB, aiming to deploy its seventh-generation robotaxis in top-tier cities and key travel hubs, marking a significant step in China's driverless commercialization push.
Shares of diabetes care innovator Insulet have tumbled nearly 10% year-to-date, sparking a fierce debate among investors. While a key valuation model suggests the stock is deeply undervalued, its sky-high P/E ratio tells a conflicting story. We examine the numbers and what they mean for the future of the Omnipod maker.
U.S. producer prices rose more than expected in December, driven by the largest increase in service costs in months, complicating the inflation outlook as the Federal Reserve weighs its next policy move.
The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.
Florida-based Seacoast Banking Corporation (SBCF) capped off 2025 with robust loan growth and margin expansion, fueled by its recent acquisition of Villages Bancorporation. Management outlined confident guidance for the coming year, forecasting significant earnings per share growth and improved returns.
Primis Financial (FRST) posted Q4 earnings of $29.5M, buoyed by a one-time gain. Management pegs core quarterly earnings near $8M, citing mortgage growth and deposit mix improvements as key drivers for its 2026 profitability target.
After two challenging years, Flagstar Bancorp (NYSE: FBC) reported a return to profitability in the fourth quarter of 2025, posting adjusted net income of $30 million. Executives outlined a strategic shift towards commercial lending and a strengthened balance sheet as key drivers for future performance.
